AHA 2019: Updates from the EVAPORATE Study

Published: 28 Nov 2019

  • Views:

    Views Icon 339
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating


Prof Matthew Budoff (David Geffen School of Medicine at UCLA, Los Angeles, CA, US) discusses the effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides (200-499 mg/dl) on Statin Therapy (EVAPORATE Study)



Filmed on site at AHA 2019 by Radcliffe Cardiology.

Videographer: Tom Green & Dominic Woodruff